| 8.12 Data as of Jun 19 |  -0.62 / -7.09%Today’s Change | 4.00 Today|||52-Week Range 12.70 | +80.04% Year-to-Date |
| Why Coronado Biosciences Is Poised to Keep Plunging Jun 17 / MotleyFool.com |
| Previous close | 8.74 |
| Today’s open | 8.74 |
| Day’s range | -- - -- |
| Volume | 495,057 |
| Average volume (3 months) | 377,303 |
| Market cap | $245.1M |
| Dividend yield | -- |
| Earnings growth (last year) | +76.95% |
| Earnings growth (this year) | -1.46% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 9.68 |
| Today’s change | Today’s % change | |
|---|---|---|
| PGNXProgenics Pharmaceut... | -0.01 | -0.21% |
| STSIStar Scientific Inc | -0.08 | -5.52% |
| RGENRepligen Corp | -0.23 | -2.90% |
| INSYInsys Therapeutics I... | +0.01 | +0.09% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.6M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Harlan F. Weisman, MD |
Chief Operating Officer & Executive Vice President Noah D. Beerman, MBA |
Corporate headquarters Burlington, Massachusetts |
.
